BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 11055466)

  • 1. The role of ambulatory blood pressure monitoring in elderly hypertensive patients.
    Mancia G; Parati G
    Blood Press Suppl; 2000; 2():12-6. PubMed ID: 11055466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure variability: clinical implications and effects of antihypertensive treatment.
    Parati G; Ravogli A; Frattola A; Groppelli A; Ulian L; Santucciu C; Mancia G
    J Hypertens Suppl; 1994 Jul; 12(5):S35-40. PubMed ID: 7965285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated blood pressure measurement (ABPM) in the elderly.
    Trenkwalder P
    Z Kardiol; 1996; 85 Suppl 3():85-91. PubMed ID: 8896306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Ambulatory Blood Pressure Monitoring in Elderly Hypertensive Patients.
    Parati GMG
    Blood Press; 2000; 9(sup2):12-16. PubMed ID: 28425792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ambulatory blood pressure monitoring in evaluating hypertensive patients and their treatment.
    Lacourcière Y
    Can J Cardiol; 1993; 9(1):73-9. PubMed ID: 8439831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of blood pressure control in hypertensive stroke survivors: an ambulatory blood pressure monitoring study.
    Zakopoulos N; Spengos K; Tsivgoulis G; Zis V; Manios E; Vemmos K
    Blood Press Monit; 2006 Oct; 11(5):235-41. PubMed ID: 16932032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can good surrogate end-points predict the prognosis of hypertensive patients?
    Mancia G; Lanfranchi A; Turri C; Grassi G
    J Hypertens Suppl; 1998 Oct; 16(5):S3-7. PubMed ID: 9868998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure variability and organ damage.
    Mancia G; Frattola A; Parati G; Santucciu C; Ulian L
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S6-11. PubMed ID: 7603077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Level of blood pressure control in a hypertensive population when measurements are performed outside the clinical setting.
    Félix-Redondo FJ; Fernández-Bergés D; Espinosa-Garcia J; Pozuelos-Estrada J; Molina-Martínez LM; Pérez-Castán JF; Ríos-Rivera J; Valiente-Rubio JI; Gómez-de-la-Cámara A; Rodríguez-Pascual N
    Cardiol J; 2009; 16(1):57-67. PubMed ID: 19130417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory blood pressure monitoring in children, adolescents and elderly people.
    Waeber B; Niederberger M; Nussberger J; Brunner HR
    J Hypertens Suppl; 1991 Dec; 9(8):S72-4. PubMed ID: 1795210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of ambulatory pressure monitoring for evaluating antihypertensive treatment in clinical practice].
    Fortini A; Laureano R; Nenci G; Cappelletti C
    Minerva Med; 1995 Dec; 86(12):527-35. PubMed ID: 8684679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of ambulatory blood pressure monitoring in the assessment of antihypertensive therapy.
    Waeber B; Brunner HR
    Blood Press Monit; 1999 Oct; 4(5):263-6. PubMed ID: 10547648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory 24-hour blood pressure versus self-measured blood pressure in pharmacologic trials.
    Mengden T; Weisser B; Vetter W
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S20-5. PubMed ID: 7898091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension?
    Muxfeldt ES; Salles GF
    J Hypertens; 2008 May; 26(5):878-84. PubMed ID: 18398329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory blood pressure measurement and antihypertensive therapy.
    Waeber B; Burnier M; Perret F; Nussberger J; Brunner HR
    J Hypertens Suppl; 1989 May; 7(3):S33-9. PubMed ID: 2668463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.